Implants News and Research

RSS

Allergan receives FDA approval for Natrelle 410 breast implant

The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.

20 Feb 2013

North Carolina researchers successfully coat polymer implants with YSZ bioactive film

Researchers from North Carolina State University have for the first time successfully coated polymer implants with a bioactive film. The discovery should improve the success rate of such implants - which are often used in spinal surgeries.

20 Feb 2013

Physicians do not talk to patients about psychosocial impact and long-term risks of ICDs

New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life.

20 Feb 2013

Miniature, ultra-flexible electrodes could open new possibilities for more accurate and local DBS

Some 90,000 patients per year are treated for Parkinson's disease, a number that is expected to rise by 25 percent annually. Deep Brain Stimulation (DBS), which consists of electrically stimulating the central or peripheral nervous system, is currently standard practice for treating Parkinson's, but it can involve long, expensive surgeries with dramatic side effects. Miniature, ultra-flexible electrodes developed in Switzerland, however, could be the answer to more successful treatment for this and a host of other health issues.

19 Feb 2013

Women appear to have increased risk of implant failure following total hip replacement

Women appear to have a higher risk of implant failure than men following total hip replacement after considering patient-, surgery-, surgeon-, volume- and implant-specific risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

19 Feb 2013

First Edition: February 19, 2013

Kaiser Health News staff writer Jay Hancock, working in collaboration with The Philadelphia Inquirer, reports: "Computer mistakes like the one that produced incorrect prescriptions for thousands of Rhode Island patients are probably far more common and dangerous than the Obama administration wants you to believe, says Drexel University's Dr. Scot Silverstein."

19 Feb 2013

ArthroCare fourth quarter total revenue increases 4.9% to $96.9 million

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing at MD&M West (Hall D, Booth# 1751) Dow Corning® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components.

13 Feb 2013

HRI to begin enrollment in RAD001 Phase II trial for Neurofibromatosis Type-2

House Research Institute (HRI) is recruiting patients for a Phase II clinical trial to test a medication that may slow the progression of Neurofibromatosis Type-2, commonly referred to as NF2.

13 Feb 2013

Long-acting reversible contraception with progestin may increase risk of type 2 diabetes in women

A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.

11 Feb 2013

CWRU researcher to create new materials, techniques to test knee and hip implants

A Case Western Reserve University chemistry professor has begun imbedding magnetic nanoparticles in the toughest of plastics to understand why more than 40,000 Americans must replace their knee and hip replacements annually.

6 Feb 2013

Stanmore receives FDA clearance for Sculptor Robotic Guidance Arm

Stanmore Implants, specialists in the design and manufacture of patient specific and modular orthopaedic implants, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sculptor Robotic Guidance Arm for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.

5 Feb 2013

St. Jude Medical initiates Portico Transfemoral European Trial in severe aortic stenosis

St. Jude Medical, Inc., a global medical device company, today announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.

5 Feb 2013

FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

K7 LLC's K7C Cervical Spacer, a spinal implant device using Evonik's VESTAKEEP PEEK (polyetheretherketone), has received the U.S. Food and Drug Administration's (FDA) 510(k) approval for use as an Intervertebral Body Fusion (IBF) device.

4 Feb 2013

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best to address the psychological needs of patients with cancer.

1 Feb 2013

Zimmer fourth quarter net sales increase to $1.18 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.

31 Jan 2013

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

Marblar is gamifying the process of technology transfer. We post technology on our platform in the form of a challenge, and the Marblar community then competes to uncover new problems these technologies could solve – thereby discovering new market applications for these technologies.

31 Jan 2013

MAKOplasty Hip may benefit people with degenerative joint disease

The hip is one of your body's largest weight-bearing joints and millions of Americans are suffering with hip pain. Adventist Medical Center is the first and only hospital in Oregon, providing people suffering from hip pain, an option of robotic assisted surgery. Thanks to the collaboration between orthopedic surgeons and a robot, patients can now experience less pain and quicker recovery times.

29 Jan 2013

FDA updates metal-on-metal hip replacement advice

The US Food and Drug Administration has updated its advice on the use of metal-on-metal hip replacement prostheses.

25 Jan 2013

CHLA, House Research Institute receive FDA approval to begin pediatric ABI clinical trial

L.A.-based House Research Institute and Children's Hospital Los Angeles announced today that the United States Food and Drug Administration (FDA) has given final approval to begin a clinical trial of an Auditory Brainstem Implant (ABI) procedure for children.

22 Jan 2013

Implants News and Research

Allergan receives FDA approval for Natrelle 410 breast implant

North Carolina researchers successfully coat polymer implants with YSZ bioactive film

Physicians do not talk to patients about psychosocial impact and long-term risks of ICDs

Miniature, ultra-flexible electrodes could open new possibilities for more accurate and local DBS

Women appear to have increased risk of implant failure following total hip replacement

First Edition: February 19, 2013

ArthroCare fourth quarter total revenue increases 4.9% to $96.9 million

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

HRI to begin enrollment in RAD001 Phase II trial for Neurofibromatosis Type-2

Long-acting reversible contraception with progestin may increase risk of type 2 diabetes in women

CWRU researcher to create new materials, techniques to test knee and hip implants

Stanmore receives FDA clearance for Sculptor Robotic Guidance Arm

St. Jude Medical initiates Portico Transfemoral European Trial in severe aortic stenosis

FDA approves K7 LLC's K7C Cervical Spacer for use as IBF device

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Zimmer fourth quarter net sales increase to $1.18 billion

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

MAKOplasty Hip may benefit people with degenerative joint disease

FDA updates metal-on-metal hip replacement advice

CHLA, House Research Institute receive FDA approval to begin pediatric ABI clinical trial

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News